Skip to content
The Kingdom of Bahrain authorizes the emergency use of this anti-Coronavirus vaccine
archive photo

The National Health Regulatory Authority has approved the emergency use of the anti-Coronavirus (Covid-19) vaccination, which is produced by the European “Valneva” company

The National Health Regulatory Authority has approved the emergency use of the anti-Coronavirus (Covid-19) vaccination, which is produced by the European “Valneva” company, which is specialized in developing and producing vaccines for infectious diseases, for the age group of 18 years and above. Thus, the Kingdom of Bahrain has approved the seventh An emergency use of vaccinations as part of its national efforts to tackle the Corona virus.
The decision to approve the National Authority for Regulating Health Professions and Services was based on an in-depth study of all documents submitted by the company that included the results of the study of immunity, by the Authority’s Clinical Research Committee and the Vaccination Committee of the Ministry of Health, where all documents related to the clinical study of vaccination were studied and showed positive results in prevention from the virus.